Our Pricing

Wegovy Injection Sites: Complete UK Guide to Safe Administration

Published on: June 03, 2026

Understanding the correct wegovy injection sites is essential for safe, effective treatment and optimal weight loss results. Wegovy (semaglutide) can be injected into three approved areas: the abdomen, thigh, or upper arm, with proper site rotation reducing the risk of lipodystrophy and injection site reactions. This comprehensive guide from Cured Pharmacy's clinical team explains exactly where and how to administer your Wegovy injections, backed by MHRA guidance and clinical best practice.

Approved Wegovy Injection Sites: Where to Inject Safely

The three wegovy injection sites approved by the MHRA are the abdomen (excluding a 5cm radius around the navel), the front and outer thigh, and the upper outer arm[1]. Each site offers subcutaneous tissue suitable for semaglutide absorption, though patient preference and body composition often determine the most comfortable option. Our superintendent pharmacist Tarun Kumar (GPhC 2233073) advises that the abdomen typically provides the most consistent absorption and is the easiest site for self-injection, which is why most patients begin their treatment there.

When selecting from the available wegovy injection sites, avoid areas with visible scarring, bruising, or skin abnormalities. The injection should penetrate the subcutaneous fat layer beneath the skin but above the muscle—this depth ensures optimal semaglutide release and minimises discomfort[2]. Clinical data shows that proper site selection contributes to the 15-20% average body weight reduction observed in the STEP trials, as consistent absorption maintains therapeutic drug levels throughout the week.

Wegovy Injection Sites Rotation: Why It Matters

Rotating between wegovy injection sites each week is critical to prevent lipodystrophy—a condition where subcutaneous fat breaks down or accumulates abnormally, creating lumps or depressions under the skin[3]. The recommended rotation pattern involves using a different site each week, cycling through abdomen, left thigh, right thigh, and arms if accessible. This systematic approach allows each injection area at least three weeks to recover before reuse, maintaining healthy tissue integrity.

Patients who fail to rotate wegovy injection sites properly may experience reduced drug absorption, increased injection site reactions, and visible skin changes that can become permanent. A practical rotation strategy involves dividing the abdomen into quadrants (upper left, upper right, lower left, lower right) and moving clockwise each week, then switching to the thighs. Keep a simple diary or use your phone calendar to track which site you used—this small habit significantly improves long-term treatment outcomes and comfort.

Creating Your Personal Injection Site Schedule

Establishing a consistent schedule for wegovy injection sites helps build routine and ensures proper rotation. Most patients find success with a weekly pattern: Week 1 abdomen right side, Week 2 left thigh, Week 3 abdomen left side, Week 4 right thigh, then repeat. If using the upper arm, insert it between thigh injections, though this site often requires assistance from another person to reach comfortably. Document each injection in a simple log noting the date, site, and any reactions—this record proves invaluable during follow-up consultations with your prescriber.

Abdomen Wegovy Injection Sites: Technique and Tips

The abdominal area remains the most popular among wegovy injection sites due to accessibility and generous subcutaneous fat distribution. To inject correctly, pinch approximately 5cm of skin between your thumb and forefinger, creating a raised area, then insert the needle at a 90-degree angle[4]. The injection should occur at least 5cm away from your navel in any direction, and at least 5cm from any previous injection site to allow tissue recovery.

For optimal results with abdominal wegovy injection sites, clean the area with an alcohol wipe and allow it to dry completely—injecting through wet skin increases infection risk and stinging sensation. Patients with lower body fat percentages may need to inject at a 45-degree angle instead of 90 degrees to ensure subcutaneous rather than intramuscular delivery. The abdomen's rich blood supply facilitates consistent semaglutide absorption, contributing to the medication's proven efficacy in reducing HbA1c and body weight as demonstrated in clinical trials.

Common Abdominal Injection Mistakes to Avoid

Three frequent errors with abdominal wegovy injection sites include injecting too close to the navel (which has less subcutaneous fat), reusing the exact same spot repeatedly, and failing to pinch the skin adequately before injection. Always ensure you're grasping subcutaneous tissue rather than muscle—if you feel resistance or unusual pain during injection, withdraw and reposition. Bruising occasionally occurs but should resolve within a week; persistent bruising or hard lumps warrant consultation with your prescriber or our clinical team at Cured Pharmacy.

Thigh Wegovy Injection Sites: Front and Outer Areas

The thigh offers accessible wegovy injection sites particularly suited to patients with less abdominal subcutaneous fat or those who prefer alternating away from the stomach. The correct injection zone spans the front and outer thigh, from approximately 10cm above the knee to 10cm below the hip, avoiding the inner thigh entirely due to major blood vessels and sensitive tissue in that region[1]. Sit comfortably when injecting into the thigh to relax the muscle and make the subcutaneous layer more accessible.

When using thigh wegovy injection sites, the same pinching technique applies—gather skin between thumb and forefinger, insert at 90 degrees (or 45 degrees for leaner individuals), and inject slowly. Many patients find the thigh slightly more uncomfortable than the abdomen initially, but discomfort typically diminishes with practice and proper technique. Rotating between left and right thigh, and varying the specific location within the approved zone, prevents tissue damage and maintains consistent semaglutide absorption throughout your treatment journey.

Upper Arm Wegovy Injection Sites: When and How to Use

The upper outer arm represents the third approved option among wegovy injection sites, though it's the least commonly used due to accessibility challenges—most patients require assistance to inject here properly. The correct area is the back of the upper arm, approximately halfway between the shoulder and elbow, where sufficient subcutaneous tissue exists for safe injection[2]. This site works well when rotating through all available areas or when other sites become temporarily unsuitable due to skin conditions or patient preference.

If incorporating the arm into your wegovy injection sites rotation, ensure the person assisting you understands proper technique: clean the area, pinch the skin, inject at the correct angle, and hold the pen in place for the full injection duration. The arm's smaller injection zone means you may return to abdomen and thigh sites more frequently in your rotation schedule. Regardless of which site you choose each week, consistent technique matters more than location—proper administration ensures the 2.4mg weekly semaglutide dose delivers its full therapeutic benefit.

Assessing Which Wegovy Injection Sites Work Best for You

Individual anatomy, comfort levels, and lifestyle factors determine your optimal wegovy injection sites selection. Patients with physically demanding jobs often prefer thigh injections to avoid abdominal soreness during bending or lifting, while those with limited flexibility find the abdomen most practical. Experiment during your first month to identify which sites feel most comfortable and show minimal injection site reactions—this personalised approach, combined with proper rotation, maximises treatment adherence and outcomes. Our clinical team remains available to discuss injection technique concerns during your ongoing care at Cured Pharmacy.

Wegovy Injection Sites Safety and Troubleshooting

Proper management of wegovy injection sites includes monitoring for adverse reactions such as redness, swelling, itching, or persistent pain lasting beyond 48 hours. Mild reactions affecting up to 10% of patients typically resolve without intervention, but signs of infection—increasing warmth, pus, spreading redness, or fever—require immediate medical attention[3]. Never inject into areas with active skin conditions, moles, scars, or stretch marks, as these compromise absorption and increase complication risk.

If you notice hard lumps developing at wegovy injection sites despite rotation, you may be injecting too frequently in the same general area or not allowing sufficient recovery time. Lipodystrophy, while uncommon with proper technique, can affect semaglutide absorption and treatment efficacy. Should you accidentally inject into muscle rather than subcutaneous tissue (indicated by sharp pain and rapid medication absorption), contact your prescriber—you may experience more pronounced side effects as the drug enters your system faster than intended. At Cured Pharmacy, our team provides ongoing support throughout your Wegovy treatment, available at (+44) 116 4646009 for injection technique questions or concerns.

Scientific References

1. Novo Nordisk. (2023). Wegovy (semaglutide) injection: Prescribing information and patient guidance. Electronic Medicines Compendium. [accessed 13 August 2026]
2. Wilding, J. P. H., Batterham, R. L., Calanna, S., et al. (2021). Once-weekly semaglutide in adults with overweight or obesity. New England Journal of Medicine, 384(11), 989-1002. [accessed 13 August 2026]
3. Medicines and Healthcare products Regulatory Agency. (2023). Semaglutide injection safety and administration guidelines. GOV.UK. [accessed 13 August 2026]
4. Frid, A. H., Kreugel, G., Grassi, G., et al. (2016). New injection recommendations for patients with diabetes. Diabetes & Metabolism, 42(Suppl 1), S3-S23. [accessed 13 August 2026]
5. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
6. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
7. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.